Physician profile
Wanda Berrios
NPI 1932216496
$5,466.52
in general payments reported to CMS, 2019-2025
20 companies · $614 in 2025
The $614 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $713 · 2021: $1,459 · 2022: $696 · 2023: $845 · 2024: $545 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,003.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,008.83 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $820.44 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Jardiance |
| Amarin Pharma, INC. | $740.19 | 2019-2021 | |
| Novo Nordisk INC | $568.26 | 2020-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $522.93 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $483.02 | 2019-2023 | Xarelto |
| Lilly USA, LLC | $350.59 | 2019-2023 | Jardiance, Mounjaro |
| Pfizer INC. | $243.24 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $179.86 | 2019-2022 | |
| Corcept Therapeutics | $108.71 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $86.93 | 2021-2025 | |
| Emergent Biosolutions INC. | $56.96 | 2019 | |
| Abbott Laboratories | $52.96 | 2022-2023 | Freestyle Libre |
| Sanofi-Aventis U.S. LLC | $52.68 | 2022-2023 | |
| Amgen INC. | $40.55 | 2022-2025 | Repatha, Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $38.50 | 2024-2025 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $35.90 | 2025 | Nuzyra, Xhance |
| Novartis Pharmaceuticals Corporation | $32.12 | 2022 | |
| Radius Health, INC. | $24.64 | 2024 | Tymlos |
| Mylan Specialty L.P. | $19.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Berrios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.